Total Payments
$612,981
2024 Payments
$47,062
Companies
32
Transactions
602
Medicare Patients
871
Medicare Billing
$164,035
Payment Breakdown by Category
Consulting$275,429 (44.9%)
Other$240,209 (39.2%)
Travel$80,482 (13.1%)
Food & Beverage$16,667 (2.7%)
Education$193.30 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $275,429 | 92 | 44.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $232,391 | 98 | 37.9% |
| Travel and Lodging | $80,482 | 165 | 13.1% |
| Food and Beverage | $16,667 | 234 | 2.7% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $5,768 | 2 | 0.9% |
| Honoraria | $2,050 | 2 | 0.3% |
| Education | $193.30 | 9 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $120,636 | 81 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $103,073 | 116 | $0 (2021) |
| AKEBIA THERAPEUTICS INC | $95,042 | 83 | $0 (2024) |
| Keryx Biopharmaceuticals, Inc. | $90,820 | 92 | $0 (2018) |
| PFIZER INC. | $70,263 | 43 | $0 (2019) |
| Vifor Fresenius Medical Care Renal Pharma Ltd. | $30,201 | 21 | $0 (2020) |
| Rockwell Medical, Inc. | $26,614 | 21 | $0 (2021) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $19,926 | 14 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $8,313 | 10 | $0 (2024) |
| Vifor (International) Ltd. | $7,709 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47,062 | 45 | GlaxoSmithKline, LLC. ($19,256) |
| 2023 | $82,059 | 55 | GlaxoSmithKline, LLC. ($78,648) |
| 2022 | $25,710 | 39 | GlaxoSmithKline, LLC. ($22,732) |
| 2021 | $52,103 | 43 | AKEBIA THERAPEUTICS INC ($19,150) |
| 2020 | $59,375 | 52 | AstraZeneca Pharmaceuticals LP ($32,301) |
| 2019 | $143,745 | 142 | AKEBIA THERAPEUTICS INC ($60,658) |
| 2018 | $87,262 | 111 | Keryx Biopharmaceuticals, Inc. ($59,016) |
| 2017 | $115,664 | 115 | PFIZER INC. ($57,377) |
All Payment Transactions
602 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Honoraria | Cash or cash equivalent | $1,050.00 | General |
| Category: Nephrology | ||||||
| 11/27/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Consulting Fee | Cash or cash equivalent | $7,350.00 | General |
| Category: Nephrology | ||||||
| 11/16/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $67.04 | General |
| Category: Nephrology | ||||||
| 11/16/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Travel and Lodging | In-kind items and services | $54.00 | General |
| Category: Nephrology | ||||||
| 11/16/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $47.08 | General |
| Category: Nephrology | ||||||
| 11/16/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Nephrology | ||||||
| 11/15/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Travel and Lodging | In-kind items and services | $527.96 | General |
| Category: Nephrology | ||||||
| 11/15/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Travel and Lodging | In-kind items and services | $344.60 | General |
| Category: Nephrology | ||||||
| 11/15/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Travel and Lodging | In-kind items and services | $110.00 | General |
| Category: Nephrology | ||||||
| 11/07/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $73.11 | General |
| Category: Nephrology | ||||||
| 11/05/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,920.00 | General |
| 10/26/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $42.66 | General |
| 10/24/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $48.95 | General |
| Category: Endocrinology | ||||||
| 10/23/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $128.83 | General |
| Category: Nephrology | ||||||
| 10/23/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Nephrology | ||||||
| 09/27/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $842.12 | General |
| Category: Nephrology | ||||||
| 09/27/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $360.00 | General |
| Category: Nephrology | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $64.40 | General |
| 08/29/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $141.31 | General |
| Category: Nephrology | ||||||
| 08/26/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $47.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/14/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $94.87 | General |
| Category: Nephrology | ||||||
| 07/01/2024 | Vifor (International) Ltd. | — | Consulting Fee | Cash or cash equivalent | $5,362.50 | General |
| 07/01/2024 | Vifor (International) Ltd. | — | Travel and Lodging | Cash or cash equivalent | $101.00 | General |
| 06/04/2024 | American Regent | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/29/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $114.70 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 141 | 236 | $46,309 | $15,538 |
| 2022 | 6 | 174 | 417 | $103,975 | $35,694 |
| 2021 | 6 | 262 | 609 | $164,258 | $56,816 |
| 2020 | 9 | 294 | 634 | $181,321 | $55,987 |
Total Patients
871
Total Services
1,896
Medicare Billing
$164,035
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 84 | $12,768 | $4,957 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 41 | $8,856 | $3,168 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 52 | $8,112 | $3,005 | 37.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 29 | $8,323 | $2,807 | 33.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 13 | 30 | $8,250 | $1,602 | 19.4% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Facility | 2022 | 12 | 40 | $24,400 | $10,755 | 44.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 47 | 163 | $24,776 | $8,700 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 77 | $16,632 | $6,483 | 39.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 41 | 41 | $11,767 | $4,028 | 34.2% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 13 | 44 | $12,100 | $2,866 | 23.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 16 | 52 | $14,300 | $2,862 | 20.0% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Facility | 2021 | 11 | 84 | $51,240 | $23,085 | 45.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 79 | 211 | $32,072 | $11,428 | 35.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 59 | 104 | $22,464 | $7,180 | 32.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 59 | 61 | $17,507 | $6,151 | 35.1% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 34 | 81 | $22,275 | $4,520 | 20.3% |
| 90945 | Dialysis procedure including one evaluation | Facility | 2021 | 20 | 68 | $18,700 | $4,452 | 23.8% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Facility | 2020 | 16 | 89 | $54,290 | $19,552 | 36.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 77 | 171 | $25,992 | $9,396 | 36.1% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Facility | 2020 | 17 | 32 | $16,320 | $5,919 | 36.3% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 39 | 104 | $28,600 | $5,829 | 20.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 60 | 104 | $22,464 | $5,193 | 23.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 46 | 47 | $13,489 | $4,843 | 35.9% |
| 90945 | Dialysis procedure including one evaluation | Facility | 2020 | 15 | 63 | $17,325 | $4,177 | 24.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 13 | 13 | $1,929 | $788.56 | 40.9% |
About Dr. Jay Wish, MD
Dr. Jay Wish, MD is a Nephrology healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851311922.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Wish, MD has received a total of $612,981 in payments from pharmaceutical and medical device companies, with $47,062 received in 2024. These payments were reported across 602 transactions from 32 companies. The most common payment nature is "Consulting Fee" ($275,429).
As a Medicare-enrolled provider, Wish has provided services to 871 Medicare beneficiaries, totaling 1,896 services with total Medicare billing of $164,035. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Indianapolis, IN
- Active Since 07/20/2006
- Last Updated 03/15/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1851311922
Products in Payments
- Auryxia (Drug) $105,378
- JESDUVROQ (Drug) $59,108
- AURYXIA (Drug) $45,380
- TRIFERIC (Drug) $24,554
- LOKELMA (Drug) $8,663
- Vafseo (Drug) $8,646
- Venofer (Drug) $8,627
- TARPEYO (Drug) $8,313
- RETACRIT (Biological) $7,013
- INJECTAFER (Drug) $6,462
- Rayaldee (Drug) $6,145
- SAMSCA (Drug) $5,683
- Aranesp (Biological) $4,363
- Veltassa (Drug) $3,070
- FARXIGA (Drug) $2,615
- Triferic (Drug) $2,060
- Parsabiv (Biological) $434.36
- Velphoro (Drug) $304.58
- Parsabiv (Drug) $189.16
- XPHOZAH 30 MG (Drug) $143.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Indianapolis
Rajiv Agarwal, M.d, M.D
Nephrology — Payments: $1.8M
Nephrology $1.8M
Bruce Molitoris, M.d, M.D
Nephrology — Payments: $155,177
Nephrology $155,177
Allon Friedman, M.d, M.D
Nephrology — Payments: $118,706
Nephrology $118,706
Dr. Arjun Sinha, M.d, M.D
Nephrology — Payments: $103,353
Nephrology $103,353
Sharon Moe, M.d, M.D
Nephrology — Payments: $40,018
Nephrology $40,018
Dr. James Elliott, M.d, M.D
Nephrology — Payments: $36,268
Nephrology $36,268